Health
COVID Vaccine for Patient With Rare Disease? Best Guess Is Yes – MedPage Today
Clinicians favor vaccination in most groups, including people with pulmonary hypertension
Extrapolating from the limited data from the Pfizer/BioNTech and Moderna COVID-19 vaccine trials, clinicians say the products’ benefits likely outweigh the risks for people with pulmonary hypertension and other rare diseases.
“The reality is folks with rare diseases will never have enough to do the trials out of the gate,” said Tom Maddox, MD, MSc, of BJC HealthCare and Washington University School of Medicine in St. Louis.
Without hard data, he said, clinicians and researchers can only postulate…
Continue Reading
